Predicted protein targets (top 12)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CNR2 | P34972 | 3/20 | 0.37 |
| ▸ | ALOX5 | P09917 | 1/20 | 0.37 |
| ▸ | ALDH1A1 | P00352 | 4/20 | 0.37 |
| ▸ | GAA | P10253 | 3/20 | 0.36 |
| ▸ | KMT2A | Q03164 | 3/20 | 0.36 |
| ▸ | P2RY10 | O00398 | 2/20 | 0.36 |
| ▸ | KDM4E | B2RXH2 | 3/20 | 0.36 |
| ▸ | LMNA | P02545 | 1/20 | 0.36 |
| ▸ | MEN1 | O00255 | 2/20 | 0.35 |
| ▸ | HSD17B10 | Q99714 | 2/20 | 0.34 |
| ▸ | HPGD | P15428 | 1/20 | 0.34 |
| ▸ | EPHX2 | P34913 | 1/20 | 0.34 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL3919073 | 0.91 | EPHX2 (0.37) | CNR2ALDH1A1GAAKMT2AP2RY10 | |
| SCHEMBL3005960 | 0.85 | CYP3A4 (0.40) | ALDH1A1GAAKMT2ALMNAMEN1 | |
| SCHEMBL3006059 | 0.85 | GAA (0.44) | ALOX5ALDH1A1GAAKMT2ALMNA | |
| SCHEMBL6278572 | 0.84 | ALDH1A1 (0.38) | CNR2ALOX5ALDH1A1GAAKMT2A | |
| SCHEMBL2794014 | 0.84 | APP (0.44) | CNR2ALDH1A1P2RY10KDM4ELMNA | |
| SCHEMBL29634941 | 0.83 | ALOX5 (0.44) | CNR2ALOX5GAAKMT2AP2RY10 | |
| SCHEMBL28549782 | 0.83 | ALOX5 (0.44) | CNR2ALOX5GAAKMT2AP2RY10 | |
| SCHEMBL6359662 | 0.83 | PDK2 (0.38) | CNR2ALDH1A1GAAKMT2AMEN1 | |
| SCHEMBL6302454 | 0.83 | ALOX5 (0.43) | CNR2ALOX5ALDH1A1P2RY10KDM4E | |
| SCHEMBL16210606 | 0.81 | ALDH1A1 (0.38) | CNR2ALOX5ALDH1A1GAAKMT2A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 9 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-8680183-B2 | Liquid stabilizer mixture | BASF SE (DE) | 2014-03-25 | — | — | US | disclosed |
| US-8505237-B2 | Process for enhancing plant growth | BASF SE (DE) | 2013-08-13 | — | — | US | disclosed |
| US-20120129987-A1 | LIQUID STABILIZER MIXTURE | BASE SE (DE) | 2012-05-24 | — | — | US | disclosed |
| US-20100267893-A1 | LIQUID STABILIZER MIXTURE | BASF SE (DE) | 2010-10-21 | — | — | US | disclosed |
| US-20100186294-A1 | Process for enhancing plant growth | BASF SE (DE) | 2010-07-29 | — | — | US | disclosed |
| EP-1368431-B1 | PYRIDONE DYES, A PROCESS FOR THEIR PREPARATION AND THEIR USE IN THE PRODUCTION OF COLOURED PLASTICS OR POLYMERIC COLOUR PARTICLES | CIBA SC HOLDING AG (CH) | 2007-12-05 | — | — | EP | disclosed |
| EP-1631616-A1 | NOVEL SURFACE-ACTIVE POLYSILOXANE PHOTOINITIATORS | Ciba SC Holding AG (CH) | 2006-03-08 | — | — | EP | disclosed |
| WO-2004108799-A1 | NOVEL SURFACE-ACTIVE POLYSILOXANE PHOTOINITIATORS | CIBA SPECIALTY CHEMICALS HOLDING INC. (CH) | 2004-12-16 | — | — | WO | disclosed |
| US-20040123403-A1 | Pyridone dyes, a process for their preparation and their use in the production of coloured plastics or polymeric colour particles | CIBA SPECIALTY CHEMICALS CORP. | 2004-07-01 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20100267893-A1 | LIQUID STABILIZER MIXTURE | NISCH, NPM1, PNN | CNR2 3061/4885ALOX5 3560/4885ALDH1A1 2219/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.